[LGND] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 51.71%
YoY- 82.66%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 50,382 72,473 69,990 27,003 59,590 50,464 38,185 4.72%
PBT 24,140 -7,026 3,370 -8,175 -56,789 30,665 7,230 22.24%
Tax 38,674 -2,058 -2,391 -810 -14,307 37,675 10,355 24.54%
NP -14,534 -4,968 5,761 -7,365 -42,482 -7,010 -3,125 29.18%
Tax Rate -160.21% - 70.95% - - -122.86% -143.22% -
Total Cost 64,916 77,441 64,229 34,368 102,072 57,474 41,310 7.82%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -28.85 -6.85 8.23 -27.27 -71.29 -13.89 -8.18 23.36%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.86 -0.30 0.36 -0.43 -2.02 -0.34 -0.15 33.76%
EPS Diluted -0.86 -0.30 0.35 -0.43 -2.02 -0.33 -0.15 33.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.